Beijing Winsunny Pharmaceutical CO.LTD (601089) — Capital Reinvestment Ratio
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Capital Reinvestment Ratio of 0.57x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥690.75 Million) in capital expenditures (CN¥391.52 Million). See 601089 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Winsunny Pharmaceutical CO.LTD Capital Reinvestment Ratio (2020–2024)
This chart tracks Beijing Winsunny Pharmaceutical CO.LTD's Capital Reinvestment Ratio across 5 annual periods. Check 601089 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year Capital Reinvestment Ratio for Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024. For live market cap and broader valuation context, see Beijing Winsunny Pharmaceutical CO.LTD (601089) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | CN¥690.75 Million | CN¥391.52 Million | ▼ -13.9% |
| 2023 | 0.66x | CN¥555.90 Million | CN¥366.08 Million | ▲ +220.9% |
| 2022 | 0.21x | CN¥659.76 Million | CN¥135.40 Million | ▼ -43.8% |
| 2021 | 0.37x | CN¥528.02 Million | CN¥192.97 Million | ▼ -16.4% |
| 2020 | 0.44x | CN¥386.65 Million | CN¥168.96 Million | — |